Terms: = Colorectal cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Treatment
160 results:
1. Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer.
Kayser A; Wolff A; Berlin P; Duehring L; Henze L; Mundkowski R; Bergmann W; Müller-Hilke B; Wagner C; Huehns M; Oehmcke-Hecht S; Maletzki C
Sci Rep; 2024 May; 14(1):10582. PubMed ID: 38719932
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of association between center colorectal neuroendocrine neoplasm volume and survival among patients with colorectal neuroendocrine carcinoma.
Suraju MO; Freischlag K; McKeen A; Nayyar A; Thompson D; Gordon DM; Mishra A; Sherman SK; Goffredo P; Hassan I
J Surg Oncol; 2024 Jun; 129(8):1449-1455. PubMed ID: 38685721
[TBL] [Abstract] [Full Text] [Related]
3. colorectal polypectomy and endoscopic mucosal resection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2024.
Ferlitsch M; Hassan C; Bisschops R; Bhandari P; Dinis-Ribeiro M; Risio M; Paspatis GA; Moss A; Libânio D; Lorenzo-Zúñiga V; Voiosu AM; Rutter MD; Pellisé M; Moons LMG; Probst A; Awadie H; Amato A; Takeuchi Y; Repici A; Rahmi G; Koecklin HU; Albéniz E; Rockenbauer LM; Waldmann E; Messmann H; Triantafyllou K; Jover R; Gralnek IM; Dekker E; Bourke MJ
Endoscopy; 2024 Jul; 56(7):516-545. PubMed ID: 38670139
[TBL] [Abstract] [Full Text] [Related]
4. miR-575/RIPK4 axis modulates cell cycle progression and proliferation by inactivating the Wnt/β-catenin signaling pathway through inhibiting RUNX1 in colon cancer.
Wang Q; Lu W; Lu L; Wu R; Wu D
Mol Cell Biochem; 2024 Jul; 479(7):1747-1766. PubMed ID: 38480605
[TBL] [Abstract] [Full Text] [Related]
5. Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.
Prajapati KS; Kumar S
Cell Biochem Funct; 2024 Mar; 42(2):e3959. PubMed ID: 38390770
[TBL] [Abstract] [Full Text] [Related]
6. The combination of IL-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy.
Wang D; Wang X; Zhang Y; Yu L; An J; Wang X; Huang Y; Han X
Front Immunol; 2024; 15():1309509. PubMed ID: 38352877
[TBL] [Abstract] [Full Text] [Related]
7. Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer.
Yu Z; Deng P; Chen Y; Lin D; Liu S; Hong J; Guan P; Chen J; Zhong ME; Chen J; Chen X; Sun Y; Wang Y; Wang P; Cai Z; Chan JY; Huang Y; Xiao R; Guo Y; Zeng X; Wang W; Zou Y; Yu Q; Lan P; Teh BT; Wu X; Tan J
Proc Natl Acad Sci U S A; 2024 Feb; 121(6):e2304619121. PubMed ID: 38289962
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of Autophagy Aggravates
Tsai CH; Huang HC; Lin KJ; Liu JM; Chen GL; Yeh YH; Lu TL; Lin HW; Lu MT; Chu PC
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279345
[TBL] [Abstract] [Full Text] [Related]
9. SNRPB promotes the progression of hepatocellular carcinoma via regulating cell cycle, oxidative stress, and ferroptosis.
Wang X; Zhang H; Guo Z; Wang J; Lu C; Wang J; Jin R; Mo Z
Aging (Albany NY); 2024 Jan; 16(1):348-366. PubMed ID: 38189879
[TBL] [Abstract] [Full Text] [Related]
10. First-line cdk4/6 inhibitor-based combinations for HR+/HER2- advanced breast cancer: A Bayesian network meta-analysis.
Guo X; Zhou Y; Zhang K; Lu W; Zhong X; Wu S; Shen L; Chen H; Chen Y
J Evid Based Med; 2024 Mar; 17(1):106-118. PubMed ID: 38102891
[TBL] [Abstract] [Full Text] [Related]
11. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
[TBL] [Abstract] [Full Text] [Related]
12. Potential Signature Therapeutic Biomarkers TOP2A, MAD2L1, and CDK1 in colorectal cancer: A Systems Biomedicine-Based Approach.
Priyamvada P; Ramaiah S
Biochem Genet; 2024 Jun; 62(3):2166-2194. PubMed ID: 37884851
[TBL] [Abstract] [Full Text] [Related]
13. Combination of PARP inhibitor and cdk4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides "one-two punch" opportunity with anti-PD-L1 therapy in colorectal cancer.
Wang T; Liu W; Shen Q; Tao R; Li C; Shen Q; Lin Y; Huang Y; Yang L; Xie G; Bai J; Li R; Wang L; Tao K; Yin Y
Cancer Sci; 2023 Nov; 114(11):4184-4201. PubMed ID: 37702298
[TBL] [Abstract] [Full Text] [Related]
14. Impact of BMI in Patients With Early Hormone Receptor-Positive Breast cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
Pfeiler G; Hlauschek D; Mayer EL; Deutschmann C; Kacerovsky-Strobl S; Martin M; Meisel JL; Zdenkowski N; Loibl S; Balic M; Park H; Prat A; Isaacs C; Bajetta E; Balko JM; Bellet-Ezquerra M; Bliss J; Burstein H; Cardoso F; Fohler H; Foukakis T; Gelmon KA; Goetz M; Haddad TC; Iwata H; Jassem J; Lee SC; Linderholm B; Los M; Mamounas EP; Miller KD; Morris PG; Munzone E; Gal-Yam EN; Ring A; Shepherd L; Singer C; Thomssen C; Tseng LM; Valagussa P; Winer EP; Wolff AC; Zoppoli G; Machacek-Link J; Schurmans C; Huang X; Gauthier E; Fesl C; Dueck AC; DeMichele A; Gnant M;
J Clin Oncol; 2023 Nov; 41(33):5118-5130. PubMed ID: 37556775
[TBL] [Abstract] [Full Text] [Related]
15. E3 ligase MG53 suppresses tumor growth by degrading cyclin D1.
Fang M; Wu HK; Pei Y; Zhang Y; Gao X; He Y; Chen G; Lv F; Jiang P; Li Y; Li W; Jiang P; Wang L; Ji J; Hu X; Xiao RP
Signal Transduct Target Ther; 2023 Jul; 8(1):263. PubMed ID: 37414783
[TBL] [Abstract] [Full Text] [Related]
16. Two-team Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection Using Transanal Approach for Rectal cancer: A Retrospective Study.
Shiraishi T; Ogawa H; Yamaguchi A; Shioi I; Shibasaki Y; Komine C; Ozawa N; Osone K; Okada T; Sano A; Sakai M; Sohda M; Shirabe K; Saeki H
Anticancer Res; 2023 Jul; 43(7):3311-3319. PubMed ID: 37351984
[TBL] [Abstract] [Full Text] [Related]
17. Adjuvant Palbociclib May be Associated with Delayed Recurrence in Completely Resected Retroperitoneal Liposarcoma: Results of a Single-Institution Retrospective Cohort Study.
Selby LV; Clark EC; Liebner DA; Chen JL; Tinoco G; Bashian E; Beane JD; Pollock RE; Grignol VP
Ann Surg Oncol; 2023 Nov; 30(12):7876-7881. PubMed ID: 37330448
[TBL] [Abstract] [Full Text] [Related]
18. Managing a Long and Winding Road: Estrogen Receptor-Positive Breast cancer.
Gnant M; Turner NC; Hernando C
Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390922. PubMed ID: 37319380
[TBL] [Abstract] [Full Text] [Related]
19. Endoscopic mucosal resection using cold snare versus hot snare in treatment for 10-19 mm non-pedunculated colorectal polyps: protocol of a non-inferiority randomised controlled study.
Jiang Q; Yan X; Wang D; Zhang S; Zhang Y; Feng Y; Yang A; Wu D
BMJ Open; 2023 May; 13(5):e070321. PubMed ID: 37217262
[TBL] [Abstract] [Full Text] [Related]
20. 5-Fluorouracil Combined with Rutaecarpine Synergistically Suppresses the Growth of Colon cancer Cells by Inhibiting STAT3.
Yu Z; Chan S; Wang X; Sun R; Wang M; Wang Z; Zuo X; Chen J; Zhang H; Chen W
Drug Des Devel Ther; 2023; 17():993-1006. PubMed ID: 37020802
[TBL] [Abstract] [Full Text] [Related]
[Next]
